Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Harmony Biosciences
HRMY
$2.06B
| $16.2M | ﹤0.01% |
472,028
+100,586
| +27% | +$3.46M |
|
1802
Ichor Holdings
ICHR
$2.8B
| $16.2M | ﹤0.01% |
502,293
+29,536
| +6% | +$913K |
|
|
PGRE
1803
DELISTED
Paramount Group
PGRE
| $16.2M | ﹤0.01% |
3,270,697
-682,881
| -17% | -$3.38M |
|
1804
Embecta
EMBC
$221M
| $16.2M | ﹤0.01% |
782,190
-180,834
| -19% | -$2.96M |
|
1805
Novartis
NVS
$292B
| $16.1M | ﹤0.01% |
165,442
+8,186
| +5% | +$873K |
|
1806
Beam Therapeutics
BEAM
$2.67B
| $16.1M | ﹤0.01% |
648,945
+19,453
| +3% | +$496K |
|
1807
Viasat
VSAT
$11.2B
| $16.1M | ﹤0.01% |
1,887,537
+364,072
| +24% | +$3.5M |
|
1808
AMC Entertainment Holdings
AMC
$2.54B
| $16M | ﹤0.01% |
4,032,519
+327,019
| +9% | +$1.44M |
|
|
NTST
1809
NETSTREIT Corp
NTST
$2.08B
| $16M | ﹤0.01% |
1,133,552
+55,378
| +5% | +$862K |
|
1810
Geron
GERN
$821M
| $16M | ﹤0.01% |
4,523,864
+73,482
| +2% | +$294K |
|
1811
Marten Transport
MRTN
$1.22B
| $16M | ﹤0.01% |
1,024,117
+83,686
| +9% | +$1.39M |
|
1812
Reynolds Consumer Products
REYN
$5.32B
| $16M | ﹤0.01% |
591,906
+19,044
| +3% | +$540K |
|
1813
Stock Yards Bancorp
SYBT
$2.62B
| $15.9M | ﹤0.01% |
222,632
+3,605
| +2% | +$254K |
|
|
PENG
1814
Penguin Solutions Inc
PENG
$2.7B
| $15.9M | ﹤0.01% |
829,192
+42,558
| +5% | +$777K |
|
1815
Wabash National
WNC
$508M
| $15.9M | ﹤0.01% |
925,952
+69,514
| +8% | +$1.29M |
|
|
AVDX
1816
DELISTED
AvidXchange
AVDX
| $15.8M | ﹤0.01% |
1,532,474
+3,599
| +0.2% | +$35.1K |
|
1817
Papa John's
PZZA
$1.02B
| $15.8M | ﹤0.01% |
383,892
+5,216
| +1% | +$256K |
|
1818
Dyne Therapeutics
DYN
$4.71B
| $15.7M | ﹤0.01% |
667,452
+18,800
| +3% | +$556K |
|
1819
Cimpress
CMPR
$2.4B
| $15.7M | ﹤0.01% |
218,497
-24,451
| -10% | -$1.92M |
|
1820
Xometry
XMTR
$4.81B
| $15.6M | ﹤0.01% |
366,156
+11,307
| +3% | +$320K |
|
|
VTLE
1821
DELISTED
Vital Energy
VTLE
| $15.6M | ﹤0.01% |
504,885
+103,583
| +26% | +$3.07M |
|
1822
Kymera Therapeutics
KYMR
$8.25B
| $15.6M | ﹤0.01% |
387,187
+20,346
| +6% | +$919K |
|
|
SILA
1823
DELISTED
Sila Realty Trust
SILA
| $15.5M | ﹤0.01% |
639,006
+318,737
| +100% | +$8.03M |
|
1824
Agios Pharmaceuticals
AGIO
$1.82B
| $15.5M | ﹤0.01% |
472,547
+6,927
| +1% | +$325K |
|
|
RC
1825
Ready Capital
RC
$276M
| $15.5M | ﹤0.01% |
2,266,585
+398,005
| +21% | +$2.86M |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.